artemisinin has been researched along with Infections, Helicobacter in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guan, J; Huang, P; Li, F; Liu, L; Liu, Z; Lu, L; Qi, X; Su, T; Wang, D; Wang, Y | 1 |
Bonomi, A; Coccè, V; Farronato, G; Haynes, RK; Marano, G; Masia, C; Miani, A; Scaltrito, MM; Sisto, F; Taramelli, D | 1 |
Bhakuni, RS; Chinniah, A; Das, PK; Goswami, S; Kar, SK; Pal, A | 1 |
3 other study(ies) available for artemisinin and Infections, Helicobacter
Article | Year |
---|---|
Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Topics: Animals; Anticarcinogenic Agents; Artemisinins; Artesunate; Bacterial Adhesion; Cell Line, Tumor; Cytokines; Helicobacter Infections; Helicobacter pylori; Humans; Mice, Inbred C57BL; Microbial Sensitivity Tests; NF-kappa B; Reactive Oxygen Species; Stomach Neoplasms | 2019 |
In vitro activity of artemisone and artemisinin derivatives against extracellular and intracellular Helicobacter pylori.
Topics: Anti-Infective Agents; Artemisinins; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Microbial Viability | 2016 |
Anti-Helicobacter pylori potential of artemisinin and its derivatives.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antimalarials; Artemisia annua; Artemisinins; Cell Line, Tumor; Cell Survival; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Plant Components, Aerial | 2012 |